Your browser doesn't support javascript.
loading
Polysaccharides based gastroretentive system to sustain piroxicam release: Development and in vivo prolonged anti-inflammatory effect.
Auriemma, Giulia; Cerciello, Andrea; Sansone, Francesca; Pinto, Aldo; Morello, Silvana; Aquino, Rita P.
Afiliação
  • Auriemma G; Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy. Electronic address: gauriemma@unisa.it.
  • Cerciello A; Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy; PhD Program in Drug Discovery and Development, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy.
  • Sansone F; Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy.
  • Pinto A; Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy.
  • Morello S; Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy.
  • Aquino RP; Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084 Fisciano, (SA), Italy.
Int J Biol Macromol ; 120(Pt B): 2303-2312, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30171948
A gastro-retentive delivery system loaded with piroxicam with a bimodal release profile in gastrointestinal-tract was developed. Piroxicam is characterized by high oral absorption, long half-life, but its elimination is impaired in elderly patients. To overcome fluctuations in plasma levels, floating gastro-retentive gel-beads with sustained release properties were manufactured using prilling. Beads matrix was designed as a hollow/multipolymeric system based on alginate, ALM-pectin and hydroxypropilmethylcellulose. This research studied variables able to affect particles micromeritics, hollow inner structure, floating properties and drug-release profiles in gastro-intestinal tract. The gastro-retentive formulation (F4) acted as a floating-system able to provide the desired bimodal drug-release pattern controlling and delaying in vitro piroxicam release. The in vivo anti-inflammatory activity of the floating beads resulted prolonged up to 48 h, compared to standard piroxicam. This formulation may be proposed to treat chronic inflammatory-diseases in elderly patients, needing a rapid onset of drug action followed by a maintenance dose.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Piroxicam / Anti-Inflamatórios não Esteroides / Alginatos / Mucosa Gástrica Limite: Animals Idioma: En Revista: Int J Biol Macromol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Piroxicam / Anti-Inflamatórios não Esteroides / Alginatos / Mucosa Gástrica Limite: Animals Idioma: En Revista: Int J Biol Macromol Ano de publicação: 2018 Tipo de documento: Article